Sign up to save your podcasts
Or
Share Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile
Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.
Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet GroupLeonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.
Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Infectious Diseases in conversation with
View all
Science Magazine Podcast
811 Listeners
JAMA Editors' Summary
131 Listeners
Global News Podcast
7,901 Listeners
WSJ What’s News
4,358 Listeners
This Week in Virology
2,052 Listeners
NEJM This Week
325 Listeners
Let's Talk ID
130 Listeners
Dan Snow's History Hit
4,675 Listeners
The Daily
111,864 Listeners
Up First from NPR
56,221 Listeners
Today, Explained
10,141 Listeners
The Lancet Voice
23 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Oncology in conversation with
1 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Rest Is History
12,979 Listeners
The Lancet Respiratory Medicine in conversation with
2 Listeners
The Lancet in conversation with
1 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Healthy Longevity in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
ID:IOTS - Infectious Disease Insight Of Two Specialists
24 Listeners
eClinicalMedicine in conversation with
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
The Rest Is Politics
3,276 Listeners
Infectious Disease Puscast
82 Listeners
The Lancet Regional Health in conversation with
0 Listeners